2014
Subcutaneous Treprostinil for Pulmonary Hypertension in Chronic Lung Disease of Infancy
Ferdman DJ, Rosenzweig EB, Zuckerman WA, Krishnan U. Subcutaneous Treprostinil for Pulmonary Hypertension in Chronic Lung Disease of Infancy. Pediatrics 2014, 134: e274-e278. PMID: 24982101, DOI: 10.1542/peds.2013-2330.Peer-Reviewed Original ResearchConceptsPulmonary arterial hypertensionChronic lung diseaseSevere pulmonary arterial hypertensionFormer premature infantsSubcutaneous treprostinilLung diseaseArterial hypertensionPulmonary hypertensionPremature infantsPersistent pulmonary arterial hypertensionIntravenous prostanoid therapySimilar hemodynamic effectsStandard respiratory careTargeted PAH therapyWeeks of therapyCatheter-related complicationsRight ventricular functionCentral venous accessSubgroup of patientsLife-threatening diseasePAH therapyProstanoid therapyConservative therapyHemodynamic effectsPreterm infants
2011
Common Atrium and Pulmonary Vascular Disease
Ferdman DJ, Brady D, Rosenzweig EB. Common Atrium and Pulmonary Vascular Disease. Pediatric Cardiology 2011, 32: 595-598. PMID: 21344289, DOI: 10.1007/s00246-011-9919-6.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAge FactorsBiopsyCardiac CatheterizationChildChild, PreschoolEchocardiographyFemaleFollow-Up StudiesHeart AtriaHeart Defects, CongenitalHeart Septal Defects, AtrialHeart Septal Defects, VentricularHumansHypertension, PulmonaryInfantMalePulmonary ArteryVascular ResistanceYoung AdultConceptsPulmonary vascular diseaseVascular diseaseCommon atriumEarly pulmonary vascular diseaseSevere pulmonary vascular diseaseLarge atrial septal defectPulmonary hypertension therapyUnderwent surgical repairAtrial septal defectClinical courseSurgical repairCase seriesHypertension therapySeptal defectSurgical correctionPatientsDiseaseAtriumAge 2Early monitoringFirst yearTherapy